J. A. Bluestone, K. Herold, and G. Eisenbarth, Genetics, pathogenesis and clinical interventions in type???1 diabetes, Nature, vol.464, issue.7293, 2010.
DOI : 10.1038/nature08933

K. C. Herold, W. Hagopian, J. A. Auger, E. Poumian-ruiz, L. Taylor et al., Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus, New England Journal of Medicine, vol.346, issue.22, 2002.
DOI : 10.1056/NEJMoa012864

M. D. Pescovitz, C. J. Greenbaum, H. Krause-steinrauf, D. J. Becker, S. E. Gitelman et al., Type 1 diabetes TrialNet anti-CD20 study group, Rituximab, B-lymphocyte depletion, and preservation of beta-cell function, N. Engl. J. Med, pp.361-2143, 2009.

T. Orban, B. Bundy, D. J. Becker, L. A. Dimeglio, S. E. Gitelman et al., Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial, The Lancet, vol.378, issue.9789, pp.412-419, 2011.
DOI : 10.1016/S0140-6736(11)60886-6

C. H. Polman, P. W. O-'connor, E. Havrdova, M. Hutchinson, L. Kappos et al., AFFIRM Investigators, a randomized, placebocontrolled trial of natalizumab for relapsing multiple sclerosis, N. Engl. J. Med, vol.354, issue.899, 2006.

B. Keymeulen, E. Vandemeulebroucke, A. G. Ziegler, C. Mathieu, L. Kaufman et al., Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes, New England Journal of Medicine, vol.352, issue.25, pp.352-2598, 2005.
DOI : 10.1056/NEJMoa043980

L. Chaillous, H. Lef-evre, C. Thivolet, C. Boitard, N. Lahlou et al., Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial, Diab ete Insuline Orale group, pp.356-545, 2000.

D. M. Bitar and C. C. Whitacre, Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein, Cellular Immunology, vol.112, issue.2, 1988.
DOI : 10.1016/0008-8749(88)90305-X

S. D. Miller, D. M. Turley, and J. R. , Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease, Nature Reviews Immunology, vol.11, issue.9, 2007.
DOI : 10.1038/nri2153

P. Blancou, V. Tardif, T. Simon, S. Emy, and L. , Carre~ no, A. Kalergis, I. Anegon, Immunoregulatory properties of heme oxygenase-1, Methods Mol. Biol. Clifton N. J, vol.677, issue.247, 2011.

T. Simon, I. Anegon, and P. Blancou, Heme oxygenase and carbon monoxide as an immunotherapeutic approach in transplantation and cancer, Immunotherapy, vol.3, issue.4s, 2011.
DOI : 10.2217/imt.11.43

C. Hu, H. Lin, M. Chiang, P. Chang, and L. Chau, Systemic Expression of Heme Oxygenase-1 Ameliorates Type 1 Diabetes in NOD Mice, Diabetes, vol.56, issue.5, pp.6-0495, 2007.
DOI : 10.2337/db06-0495

M. Li, S. Peterson, D. Husney, M. Inaba, K. Guo et al., Long-Lasting Expression of HO-1 Delays Progression of Type I Diabetes in NOD Mice, Cell Cycle, vol.6, issue.5, 2007.
DOI : 10.4161/cc.6.5.3917

A. A. Chora, P. Fontoura, A. Cunha, T. F. Pais, S. Cardoso et al., Heme oxygenase???1 and carbon monoxide suppress autoimmune neuroinflammation, Journal of Clinical Investigation, vol.117, issue.2, 2007.
DOI : 10.1172/JCI28844DS1

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1770945

C. Chauveau, S. Emy, P. J. Royer, M. Hill, S. Tanguy-royer et al., Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression, Blood, vol.106, issue.5, 2005.
DOI : 10.1182/blood-2005-02-0494

S. R. Emy, P. Blancou, L. Tesson, V. Tardif, R. Brion et al., Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity, J. Immunol. Balt. Md, issue.182, p.1950, 2009.

T. Simon, S. Pogu, V. Tardif, K. Rigaud, S. Emy et al., Carbon monoxide-treated dendritic cells decrease b1-integrin induction on CD8 þ T cells and protect from type 1 diabetes, Eur. J. Immunol, vol.43, issue.209, 2013.
DOI : 10.1002/eji.201242684

K. E. Anderson, J. R. Bloomer, H. L. Bonkovsky, J. P. Kushner, C. A. Pierach et al., Recommendations for the Diagnosis and Treatment of the Acute Porphyrias, Annals of Internal Medicine, vol.142, issue.6, pp.142-439, 2005.
DOI : 10.7326/0003-4819-142-6-200503150-00010

C. Vizler, N. Bercovici, A. Heurtier, N. Pardigon, K. Goude et al., Relative Diabetogenic Properties of Islet-Specific Tc1 and Tc2 Cells in Immunocompetent Hosts, The Journal of Immunology, vol.165, issue.11, pp.1950-6314, 2000.
DOI : 10.4049/jimmunol.165.11.6314

K. A. Hogquist, S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan et al., T cell receptor antagonist peptides induce positive selection, Cell, vol.76, issue.1, pp.17-27, 1994.
DOI : 10.1016/0092-8674(94)90169-4

J. Auwerx, The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation, Experientia, vol.24, issue.1, pp.22-31, 1991.
DOI : 10.1007/BF02041244

D. Roulois, V. Vignard, F. Gueugnon, N. Labarri-ere, M. Gr-egoire et al., Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8þ T-cells, Eur. Respir. J, vol.38, 2011.

C. Kurts, J. F. Miller, R. M. Subramaniam, F. R. Carbone, and W. R. Heath, Major Histocompatibility Complex Class I???restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction, The Journal of Experimental Medicine, vol.155, issue.2, pp.409-414, 1998.
DOI : 10.1084/jem.176.2.553

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212442

H. Dodt, U. Leischner, A. Schierloh, N. , C. P. Mauch et al., Ultramicroscopy: threedimensional visualization of neuronal networks in the whole mouse brain, Nat. Methods, vol.4, issue.331, 2007.

A. Ertürk, K. Becker, N. , C. P. Mauch, C. D. Hojer et al., Three-dimensional imaging of solventcleared organs using 3DISCO, Nat. Protoc, vol.7, 2012.

N. Poirier, T. Haudebourg, C. Brignone, N. Dilek, J. Hervouet et al., Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(þ) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates, Clin. Exp. Immunol, vol.164, issue.265, 2011.

I. A. Parish, J. Waithman, G. M. Davey, G. T. Belz, J. D. Mintern et al., Tissue destruction caused by cytotoxic T lymphocytes induces deletional tolerance, Proceedings of the National Academy of Sciences, vol.167, issue.2, 2009.
DOI : 10.1084/jem.171.2.377

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656177

E. Segura and S. Amigorena, Inflammatory dendritic cells in mice and humans, Trends in Immunology, vol.34, issue.9, 2013.
DOI : 10.1016/j.it.2013.06.001

URL : https://hal.archives-ouvertes.fr/inserm-00846095

C. Shi and E. G. Pamer, Monocyte recruitment during infection and inflammation, Nature Reviews Immunology, vol.182, issue.11, 2011.
DOI : 10.1038/nri3070

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947780

C. Tsou, W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian et al., Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites, Journal of Clinical Investigation, vol.117, issue.4, 2007.
DOI : 10.1172/JCI29919

S. Tamoutounour, M. Guilliams, F. Sanchis, H. Liu, D. Terhorst et al., Origins and Functional Specialization of Macrophages and of Conventional and Monocyte-Derived Dendritic Cells in Mouse Skin, Immunity, vol.39, issue.5, pp.925-938, 2013.
DOI : 10.1016/j.immuni.2013.10.004

V. Angeli, C. Faveeuw, O. Roye, J. Fontaine, E. Teissier et al., in the Inhibition of Epidermal Langerhans Cell Migration during Schistosomiasis Infection, The Journal of Experimental Medicine, vol.27, issue.10, pp.1135-1147, 2001.
DOI : 10.1111/j.1365-2133.1991.tb14789.x